These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18865039)

  • 41. Feeds, feed supplements, and medicated feeds for live stock under the Federal Food, Drug and Cosmetic Act.
    MOSKEY HE
    North Am Vet; 1948 Nov; 29(11):701-3. PubMed ID: 18891552
    [No Abstract]   [Full Text] [Related]  

  • 42. The case for a substantial evidence amendment to the informal rulemaking provision of the Federal Food, Drug, and Cosmetic Act.
    Bachrach EE
    Food Drug Law J; 2000; 55(3):293-9. PubMed ID: 11824461
    [No Abstract]   [Full Text] [Related]  

  • 43. Federal preemption of common law tort awards by the Federal Food, Drug, and Cosmetic Act.
    Carrier MK
    Food Drug Law J; 1996; 51(4):509-611. PubMed ID: 11797729
    [No Abstract]   [Full Text] [Related]  

  • 44. [Supervision of cosmetic products].
    Urbanek-Karłowska B; Smietanka B; Pawłowska K; Biernat U; Burzyńska I
    Rocz Panstw Zakl Hig; 2001; 52(3):257-65. PubMed ID: 11771119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FEDERAL Food, Drug and Cosmetic Act: sale of misbranded testosterone.
    J Am Med Assoc; 1953 Feb; 151(8):671-2. PubMed ID: 13011074
    [No Abstract]   [Full Text] [Related]  

  • 46. Cosmetic legislation: benefit-risk.
    Kleinfeld V
    J Am Med Womens Assoc (1972); 1974 Jul; 29(7):306-9. PubMed ID: 4376557
    [No Abstract]   [Full Text] [Related]  

  • 47. Mixed bag for industry as key drug act moves towards reauthorization.
    Wadman M
    Nat Rev Drug Discov; 2007 Jun; 6(6):421-2. PubMed ID: 17633786
    [No Abstract]   [Full Text] [Related]  

  • 48. The Food and Drug Administration; our mutual responsibility.
    HOLLAND AH
    N Y State J Med; 1955 Aug; 55(16):2327-30. PubMed ID: 13244856
    [No Abstract]   [Full Text] [Related]  

  • 49. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The authority of a court to order disgorgement for violations of the Current Good Manufacturing Practices requirement of the Federal Food, Drug, and Cosmetic Act.
    King E; Walsh EM
    Food Drug Law J; 2003; 58(2):149-68. PubMed ID: 12866550
    [No Abstract]   [Full Text] [Related]  

  • 52. The Food and Drug Administration and the Pharmaceutical industry.
    KLUMPP TG
    J Indiana State Med Assoc; 1961 Nov; 54():1680-90. PubMed ID: 14457165
    [No Abstract]   [Full Text] [Related]  

  • 53. Nanotechnology in cosmetics.
    Katz LM; Dewan K; Bronaugh RL
    Food Chem Toxicol; 2015 Nov; 85():127-37. PubMed ID: 26159063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cosmetic legislation: the need.
    Menkart J
    J Am Med Womens Assoc (1972); 1974 Aug; 29(8):362-3 passim. PubMed ID: 4367668
    [No Abstract]   [Full Text] [Related]  

  • 55. [Cosmetic legislation].
    Veylon R
    Nouv Presse Med; 1975 Oct; 4(35):2531-2. PubMed ID: 1196881
    [No Abstract]   [Full Text] [Related]  

  • 56. Remarks on proposed cosmetic legislation pending in Congress.
    McNamara SH
    J Am Med Womens Assoc (1972); 1974 Aug; 29(8):366-7 passim. PubMed ID: 4367669
    [No Abstract]   [Full Text] [Related]  

  • 57. [Statement of ingredients of cosmetics].
    de Groot AC; van Ginkel CJ; Weijland JW
    Ned Tijdschr Geneeskd; 1997 Sep; 141(36):1747-8. PubMed ID: 9545719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Reform in food legislation. Laws for advertising of cosmetics are under consideration].
    Zahnarztl Mitt; 1971 Apr; 61(7):322-3. PubMed ID: 5280113
    [No Abstract]   [Full Text] [Related]  

  • 59. The Orphan Drug Act and the Federal Government's Orphan Products Development Program.
    Finkel MJ
    Public Health Rep; 1984; 99(3):313-6. PubMed ID: 6429731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RECENT DRUG LEGISLATION IN THE UNITED STATES.
    AESCHLIMANN J
    Pharm Acta Helv; 1964; 39():193-6. PubMed ID: 14246809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.